Time is of the essence in establishing the diagnosis of stroke and determining whether the patient is a candidate for thrombolytic therapy, ideally initiated within the “golden hour” after arrival at ...
TNKase is administered as a single intravenous bolus over 5 seconds. The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in ...
Every minute counts during a stroke. Experts say early diagnosis and prompt treatment can reverse paralysis and prevent ...
20d
Health Canada authorizes TNKase(R) (tenecteplase) for the treatment of Acute Ischemic Stroke (AIS)
The approval marks the first new stroke treatment authorized in nearly 27 years, offering an additional option for managing acute ischemic stroke in Canada. MISSISSAUGA, ON, Dec. 17, 2025 /CNW/ - ...
Brain edema is a life-threatening condition where excess fluid causes the brain to swell. The primary medical treatment involves hyperosmolar agents like mannitol and hypertonic saline to draw fluid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback